Insider Transactions in Q3 2021 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
137,495
-1.03%
|
$137,495
$1.12 P/Share
|
Sep 29
2021
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,650,000
+33.95%
|
-
|
Sep 29
2021
|
Brian Lenz EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
900,000
+36.05%
|
-
|
Sep 29
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
82,505
-0.61%
|
$82,505
$1.16 P/Share
|
Sep 28
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,603
-0.3%
|
$40,603
$1.22 P/Share
|
Sep 27
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-1.82%
|
$250,000
$1.23 P/Share
|
Sep 24
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-1.78%
|
$250,000
$1.26 P/Share
|
Sep 23
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
780,000
-5.27%
|
$780,000
$1.27 P/Share
|
Aug 19
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
350,352
-2.31%
|
$350,352
$1.24 P/Share
|
Aug 18
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
552,380
-3.52%
|
$552,380
$1.29 P/Share
|
Aug 17
2021
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
879,092
-5.3%
|
$879,092
$1.35 P/Share
|